Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
Clinical Profile of chronic hepatobiliary disorders in children: experience from tertiary referral centre in western India
 
Ira Shah 1, Susmita Bhatnagar2
Department of Pediatric Medicine1 and Pediatric Surgery2
Hepatobiliary Clinic, B. J. Wadia Hospital for Children,
Parel, Mumbai-400012


Corresponding Author
: Dr. Ira Shah
Email:irashah@pediatriconcall.com


Abstract

Aim: To determine etiological spectrum as well as clinical profile of chronic hepatobiliary disorders in children. 

Methods: 45 children with chronic hepatobiliary disorders were evaluated in the study.out of 105 children with liver diseases referred to the clinic. . All underwent detailed history and clinical examination. Clinical and laboratory features as well as causes of chronic hepatobiliary disorders were studied. 

Results:- The common causes were biliary atresia in 11 (25%) patients, neonatal hepatitis and Wilson’s disease in 6 (13%) patients each, glycogen storage disorder (GSD) and idiopathic hepatitis in 5 patients (11%) each, Hepatitis B in 2 (5%), Hepatitis C in 1 (2%), Hepatitis B and C in 1 (2%), Caroli’s disease in 2 (5%), autoimmune hepatitis in 2 (5%); sclerosing cholangitis, viral hemophagocytosis and thalassemia major in 1 (2%) patient each. Common clinical presentations were jaundice in 32 (71%), dark urine in 19 (42%), fever in 13 (29%), failure to thrive in 7 (16%), splenomegaly in 21 (47%) and hepatomegaly in 32 (71%). Also children with neonatal cholestasis presented in 1st year of life, those with idiopathic liver disease and GSD presented within 1st 5 years of life and those with Wilson’s disease. Autoimmune hepatitis, Caroli’s disease presented between 5-10 years of age and viral hepatitis was seen in 2nd decade of life (p <0.001). 

Conclusion: - Commonest cause of chronic hepatobiliary disorders in children is neonatal hepatitis. Metabolic liver disease usually presents in 1st 5 years of life whereas chronic viral hepatitis has a presentation in adolescence.